Work

Personalizing Evidence-Based Primary Prevention With Aspirin

Year: 2011

Type: editorial

Abstract: O ne of the unfortunate side consequences of evidence- based medicine (EBM) is that sometimes there is no escaping how small the benefit of any individual treatment may seem.In the "days of the giants," doctors saved lives; now we can consult league tables that bloodlessly inform us how many patients-10, 50, or 200 -must receive a treatment to avert even a single bad outcome, 1 EBM's venerable number needed to treat.

Source: Circulation Cardiovascular Quality and Outcomes

DOI: 10.1161/circoutcomes.111.961136

Authors: David M. Kent, Nilay D. Shah

Institutions: Tufts University, Tufts Medical Center, Mayo Clinic, Tufts Clinical and Translational Science Institute

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Institute of Neurological Disorders and Stroke, National Center for Research Resources, National Center for Advancing Translational Sciences